Dermatology Drugs Market
According to Intent Market Research, the Dermatology Drugs Market is expected to grow from USD 37.5 billion in 2023 at a CAGR of 8.6% to touch USD 66.7 billion by 2030. The Dermatology Drugs Market is dominated by key players such as Johnson & Johnson, Novartis International AG, Pfizer Inc., AbbVie Inc., GlaxoSmithKline PLC, Bristol-Myers Squibb, Eli Lilly and Co., Sanofi S.A., Amgen Inc., Mylan N.V., Dermira, Inc. (Acquired by Eli Lilly), L'Or–al S.A., Bayer AG, Regeneron Pharmaceuticals, Sun Pharmaceutical Industries Ltd